Living with depression that does not respond to standard treatments is incredibly hard for patients and doctors alike. Currently, many experts define this condition simply by counting how many medications a person has tried without success. However, this method is often inconsistent and makes it difficult to provide the right care for everyone.
Researchers are looking for better ways to identify these cases. They found that things like poor treatment adherence or other health issues can sometimes look like a drug just isn't working. This is called pseudo-resistance. By looking closer at these factors, doctors may be able to tell the difference between a patient who needs a new approach and one whose current plan just needs better management.
The review also highlights how biology might play a role. While we still have gaps in our knowledge, there are promising signs that genetics, inflammation, and personality traits could help predict which patients will struggle most. Moving toward more specific definitions helps move the field toward precision psychiatry, where treatment is tailored to the individual's unique profile.